A Healthcare Company

Joined June 2025
4 Photos and videos
RT @DrRyanSaadi: The most powerful pharmacy in the world isn’t on a street corner. It’s already inside our veins. @TevogenBio - #Tcell 🌐 h…
5
RT @TevogenBio: 📰 globenewswire.com/news-relea… “Tevogen’s evaluation of potential MSO and CRO acquisitions reflects a disciplined approach to b…
4
RT @TevogenBio: At JPM43 Mittul Mehta, @Head_TevogenAI and @drhew Chief Medical Officer & VP of Healthcare at @Microsoft discussed AI in Bi…
4
RT @TevogenBio: Dr. Neal Flomenberg, Chief Scientific Officer, and Lori Grosso, Clinical Lead, discussed @TevogenBio's goal of making cytot…
1
RT @TevogenBio: 📰 tevogen.com/press-release/te… “Capital discipline and preserving the integrity of our capital structure are core priorities fo…
1
RT @TevogenBio: 📰 tevogen.com/press-release/te… “We anticipate this opportunity together with previously announced CRO evaluation and other stra…
3
RT @TevogenBio: 📰 tevogen.com/press_release/le… 🔹Loss from operations declined 51%, from $53.6 million in 2024 to $26.1 million in 2025. 🔹Q1 20…
5
RT @TevogenBio: 📰 tevogen.com/press_release/te… “Having The Patel Family, LLP continue to support Tevogen reflects a shared belief in both our m…
3
RT @TevogenBio: 📰 globenewswire.com/news-relea… “Advancing PredicTcell toward completion marks an important milestone in our AI strategy,” said…
4
RT @TevogenBio: 🔗 databricks.com/blog/tevogen-… As part of our ongoing work on PredicTcell™, we’ve been leveraging scalable data infrastructure…
4
RT @TevogenBio: 📰 globenewswire.com/news-relea… With compliance restored, Tevogen continues to advance its evolution into a diversified, fully i…
1
RT @TevogenBio: 📰 globenewswire.com/news-relea… @DrRyanSaadi, Founder and CEO of Tevogen stated, "Long COVID is a clinical emergency affecting h…
3
RT @TevogenBio: 📰 globenewswire.com/news-relea… “The potential acquisition of a CRO could introduce revenue-generating service capabilities whil…
1
23
📰 globenewswire.com/news-relea… Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus $TVGN #Sciometrix #Clinicus #HealthcareTechnology #Revenue #Strategy @TevogenBio @TevogenAI
1
4
5
488
The potential transaction is being explored to augment Tevogen’s existing capabilities and would result in Tevogen becoming a revenue-generating healthcare enterprise. $TVGN #Sciometrix #Clinicus #HealthcareTechnology #Revenue #Strategy
1
2
95
RT @TevogenBio: 👏On February 15, Tevogen marked two years as a publicly traded company on @NasdaqExchange .👏 Over the past year, we streng…
3
📰 globenewswire.com/news-relea… Tevogen announced its Board will evaluate a potential one-time special cash dividend, contingent on future revenue and earnings milestones and Board approval. $TVGN @Nasdaq #ShareholderValue #CapitalDiscipline
3
6
2,114
RT @TevogenBio: 📰 globenewswire.com/news-relea… “Tevogen began as a T cell therapy biotech and has since evolved into a diversified healthcare c…
3
RT @TevogenBio: 📢 From Mittul Mehta, Tevogen CIO and Head of @TevogenAI Reflecting on the past year at Tevogen.AI, I’m proud…
5
RT @TevogenBio: 🎙Q&A with Tevogen CEO🎙 Q. As Tevogen continues to build long-term value, how do you think about capital allocation and sha…
3